Sign up to save your podcasts
Or
Share 04.29.25: Drug Spending, Biosimilars, Platform Transition, and More
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
04.29.25: Drug Spending, Biosimilars, Platform Transition, and More
Welcome to the IBX EdgeCast!
This episode covers five topics from the last two weeks, straight from our Independence Edge newsletters: 2024 Drug Spend, RxDC Data Collection, Stelara and Actemra Biosimilar Strategy, Platform Transition, and EdgeCast Sign-Up Updates.
Please check out the links below for full Independence Edge articles on selected topics from this week.
Story 1: Top Drug Spend
Story 2: 2024 Prescription Drug Data Collection (RxDC)
Story 3: Stelara® and Actemra® Biosimilar Strategy
Story 4: Platform Transition
Story 5: Subscribe to EdgeCast Text Notifications
View all episodes
By Independence Blue CrossWelcome to the IBX EdgeCast!
This episode covers five topics from the last two weeks, straight from our Independence Edge newsletters: 2024 Drug Spend, RxDC Data Collection, Stelara and Actemra Biosimilar Strategy, Platform Transition, and EdgeCast Sign-Up Updates.
Please check out the links below for full Independence Edge articles on selected topics from this week.
Story 1: Top Drug Spend
Story 2: 2024 Prescription Drug Data Collection (RxDC)
Story 3: Stelara® and Actemra® Biosimilar Strategy
Story 4: Platform Transition
Story 5: Subscribe to EdgeCast Text Notifications